Corcept Therapeutics Incorporated (CORT)
Receivables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 675,040 | 628,555 | 569,610 | 523,529 | 482,375 | 450,026 | 428,153 | 413,824 | 401,858 | 397,624 | 392,027 | 380,229 | 365,978 | 352,891 | 343,087 | 340,064 | 353,874 | 356,034 | 351,212 | 334,904 |
| Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $675,040K ÷ $—K
= —
The receivables turnover for Corcept Therapeutics Incorporated is not provided for the periods up to December 31, 2024. Receivables turnover is a critical financial metric that indicates how efficiently a company is collecting its outstanding receivables from customers during a specific period. It is calculated by dividing net credit sales by the average accounts receivable balance.
Given the absence of data on receivables turnover, it is not possible to evaluate the company's ability to efficiently manage its accounts receivable and convert them into cash. A higher receivables turnover ratio typically indicates that the company is collecting its receivables quickly, which is a positive indicator of financial health.
Without specific numerical values for the receivables turnover ratio, it is challenging to provide a detailed analysis or make any conclusions regarding Corcept Therapeutics Inc.'s effectiveness in managing its accounts receivable. Investors and analysts should look for updated financial reports or disclosures to assess the company's liquidity and collection efficiency in the future.
Peer comparison
Dec 31, 2024